Abstract
Cardiac amyloidosis is an infiltrative abnormality that causes myocardial thickening and dysfunction. Historically, it has been underrecognized as a cause of heart failure and was often misdiagnosed. In the past decade, the cardiology community has improved the understanding of the subtypes of these protein-based infiltrates and how they play a role in heart failure. This article reviews the pathophysiology, presentation, diagnosis, and management of cardiac amyloidosis.
MeSH terms
-
Amyloid Neuropathies, Familial
-
Amyloidosis / diagnosis*
-
Amyloidosis / etiology
-
Amyloidosis / pathology
-
Amyloidosis / therapy*
-
Cardiomyopathies / diagnosis*
-
Cardiomyopathies / etiology
-
Cardiomyopathies / pathology
-
Cardiomyopathies / therapy*
-
Diagnosis, Differential
-
Diagnostic Errors / prevention & control
-
Echocardiography
-
Heart Failure / etiology
-
Humans
-
Immunoglobulin Light Chains
-
Immunoglobulin Light-chain Amyloidosis
-
Myocardium / pathology
-
Prealbumin
Substances
-
Immunoglobulin Light Chains
-
Prealbumin
Supplementary concepts
-
Amyloidosis, Hereditary, Transthyretin-Related